CULLEN MICHAEL T. (Exec. Chairman, Pres. & CEO) purchased 80.7% of their position (165K shares) of PANBELA THERAPEUTICS, INC. on the open market
Open‑market purchases signal personal conviction — classified as a major conviction buy.
P · 1 purchase
Filed: 10/6/2022ACC: 0001437749-22-023776
DirectorOfficer10% Owner· Exec. Chairman, Pres. & CEO
Since Dec 2018
+412K
Net shares
Net buyer
$0.00
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
412K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+165K
Price / share
—
Trade value
—
% of position
80.7%
10/4/2022
204.58K→369.58K
Total
Net shares
+165K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/4/2022 | P · Purchase | +165K | — | — | 80.7% | 204.58K | 369.58K |
| Total | +165K | $0.00 | ||||||
Derivative Transactions1
Warrants (right to buy)
Indirect
Converts to
Common Stock
247K shares
Shares
+247K
Strike price
0.30
Held after
247K
Exercisable
—
10/4/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants (right to buy) Indirect | Common Stock247K shares | 10/4/2022 | P · Purchase | +247K | 0.30 | — | 247K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned216.81K
Total
216.81K direct216.81K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 216.81K | Direct |
| Total | 216.81K | 216.81K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported